FundingΒΆ

ENA is developed and operated under the support of the European Molecular Biology Laboratory (EMBL) and through grants from external bodies that include the European Commission, the British Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust (WT).